Webcast Alert: Aethlon Medical, Inc. Presentation at Informed Investors Security and Defense Virtual Stocks Forum to be Webcast on Thursday, July 29, 2004, 10:00 am ET LA JOLLA, Calif., July 27 /PRNewswire/ -- Aethlon Medical, Inc. (OTC:AEMD) (BULLETIN BOARD: AEMD) will present at the following forum: What: Aethlon Medical, Inc. (OTC:AEMD) (BULLETIN BOARD: AEMD) will give a presentation at Informed Investors Security and Defense Virtual Stocks Forum. Additional presenting companies include: TASER International, IPIX Corp., Isis Pharmaceuticals and Law Enforcement Associates, Inc. Forum keynotes will be delivered by Jack Mallon, Founder of Mallon & Associates, at 9 am and Kevin Skislock, Partner & CEO, Laguna Research Partners, at 9:30 am. When: July 29, 2004 @ 10:00 AM Eastern Time Where: http://www.informedinvestors.com/IIF_Forum.asp?ForumID=85120 How: Live over the Internet -- Simply log on to the web at the address above. Contact: James A. Joyce, Chief Executive Officer, If you are unable to attend the live event, the forum will be available via webcast at http://www.informedinvestors.com/IIF_Forum.asp?ForumID=85120. Aethlon Medical is pioneering the development of viral filtration devices that rapidly reduce the presence of infectious disease and toxins in the body. Aethlon has published compelling human blood studies of the Hemopurifier(TM) to treat HIV/AIDS and Hepatitis-C (HCV), and most recently, has announced that it is developing pathogen filtration devices to treat infectious agents used in biological warfare and terrorism. The Hemopurifier is a proprietary platform technology that converges the established scientific principles of affinity chromatography and hemodialysis as a means to augment the immune response of clearing viruses and toxins from the blood before cell and organ infection can occur. On March 4, 2004, Aethlon announced a cooperative agreement with the National Center for Biodefense (NCBD) at George Mason University. Under the agreement, Aethlon and the NCBD will collaborate to develop pathogen and toxin filtration devices designed to protect the lives of U.S. Military personnel exposed to infectious agents as a result of biological warfare. For additional information, visit the company's Web site at http://www.aethlonmedical.com/. FORUM CONTACT: Cary Loeser, Informed Investors, 804-327-3407, Web site: http://www.informedinvestors.com DATASOURCE: Aethlon Medical, Inc. CONTACT: James A. Joyce, Chief Executive Officer of Aethlon Medical, Inc., , or Cary Loeser, Informed Investors, +1-804-327-3407, Web site: http://www.informedinvestors.com/IIF_Forum.asp?ForumID=85120 http://www.aethlonmedical.com/ http://www.informedinvestors.com/

Copyright